Related Experiment Video
Updated: May 16, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Bedding materials and early infant wheezing: A randomised controlled trial.
Caroline Halley1, Janice Kang1, Phillipa Barnes1
1Department of Medicine, University of Otago Wellington, Wellington, New Zealand.
This randomized trial found no difference in wheezing for infants using synthetic, wool, or feather bedding. Parental avoidance of feather bedding in at-risk children may explain previous observational study findings.
Area of Science:
- Pediatrics
- Environmental Health
- Allergy and Immunology
Background:
- Observational studies suggest a link between bedding materials and childhood wheezing.
- Synthetic bedding is associated with increased wheezing, while feather bedding is linked to decreased wheezing.
Purpose of the Study:
- To test the hypothesis that feather bedding reduces wheezing in infants.
- To investigate the impact of synthetic, wool, and feather bedding on respiratory health in early childhood.
Main Methods:
- A three-armed, parallel, randomized trial involving 460 infants in Wellington, New Zealand.
- Infants were assigned synthetic, wool, or feather sleepsacks from 3 months to 2 years of age.
- Wheezing, respiratory parameters, and atopic status were assessed at 2 years.
Main Results:
- No significant differences in reported or doctor-diagnosed wheezing were found across bedding material groups.
- A significantly increased rate of wheezing presentation at GP surgery was observed for children using feather materials compared to synthetic (RR 2.00, 95% CI: 1.14, 3.52).
Conclusions:
- The study does not support previous observational findings linking synthetic bedding to higher wheezing rates or feather bedding to lower rates in early childhood.
- Selection bias, where parents of at-risk children avoid feather bedding, may explain the discrepancy with observational studies.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

